Report cover image

South Korea Medical Plastics Market Size, Share, Trends, Industry Analysis Report By Polymer Type (Thermoplastics, Elastomers, Biodegradable Polymers, Others), By Application, By Manufacturing – Market Forecast, 2025–2034

Published Aug 01, 2025
Length 125 Pages
SKU # PLRS20381567

Description

The south korea medical plastics market size is expected to reach USD 1,597.39 million by 2034, according to a new study by Polaris Market Research. The report “South Korea Medical Plastics Market Size, Share, Trends, Industry Analysis Report By Polymer Type (Thermoplastics, Elastomers, Biodegradable Polymers, Others), By Application, By Manufacturing – Market Forecast, 2025–2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.

The medical plastics market focuses on supplying advanced polymer materials used in diagnostic tools, surgical instruments, implants, and disposables. Demand for medical-grade plastics is rising due to the country's shift toward high-precision, minimally invasive devices and the growing need for infection-resistant, single-use products. Growth is being driven by rapid adoption of smart medical devices, integration of automation in manufacturing, and government-backed support for domestic MedTech innovation. Local manufacturers are investing in advanced polymer processing technologies to meet increasing requirements for safety, durability, and biocompatibility. The market is also benefiting from the expanding role of plastics in wearable health monitoring devices and mobile diagnostics. Industry players are prioritizing lightweight materials that enhance design flexibility while maintaining structural strength and regulatory compliance.

The South Korea medical plastics market opportunities are emerging in custom polymer blends tailored for specific clinical applications, particularly where traditional materials fail to meet evolving safety and performance standards. Growing collaboration between polymer producers and device designers is enabling faster development of next-generation plastic-based solutions. Focus on scaling local production to reduce dependency on imports is further enhancing competitiveness in the market. Environmental concerns are prompting exploration of recyclable and bio-based alternatives, paving the way for sustainable medical plastic innovations. Continuous development in processing technologies and material formulation is expected to strengthen the market’s ability to support South Korea’s advancing healthcare infrastructure and its emphasis on precision, reliability, and patient safety.

South Korea Medical Plastics Market Report Highlights

By polymer type, the thermoplastics segment accounted for the largest revenue share of ~68% in 2024 due to their adaptability, processing ease, and wide use in high-volume medical manufacturing.

By application, the medical disposable segment is projected to register the highest CAGR of 7.8% during 2025–2034 supported by rising demand for infection-free healthcare delivery and efficiency in treatment cycles.

A few key players include Dow, Covestro AG, BASF, SABIC, Evonik Industries AG, Arkema, Celanese Corporation, Eastman Chemical Company, Solvay, Kraton Corporation, INEOS, and LG Chem.

Polaris Market Research has segmented the South Korea medical plastics market report on the basis of polymer type, application, and manufacturing:

By Polymer Type Outlook (Revenue, USD Million, 2020–2034)

Thermoplastics

Polypropylene (PP)

Polyvinyl Chloride (PVC)

Polyethylene (PE)

Polycarbonate (PC)

Polyurethane

Acrylonitrile Butadiene Styrene (ABS)

Others

Elastomers

Biodegradable Polymers

Others

By Application Outlook (Revenue, USD Million, 2020–2034)

Medical Instruments & Devices

Medical Disposable

Diagnostic Instruments & Tools

Others

By Manufacturing Outlook (Revenue, USD Million, 2020–2034)

Extrusion Tubing

Injection Molding

Compression Molding

Other

Table of Contents

125 Pages
1. Introduction
1.1. Report Description
1.1.1. Objectives of the Study
1.1.2. Market Scope
1.1.3. Assumptions
1.2. Stakeholders
2. Executive Summary
2.1. Market Highlights
3. Research Methodology
3.1. Overview
3.1.1. Data Mining
3.2. Data Source
3.2.1. Primary Source
3.2.2. Secondary Source
4. South Korea Medical Plastics Market Insights
4.1. South Korea Medical Plastics Market – Market Snapshot
4.2. South Korea Medical Plastics Market Dynamics
4.2.1. Drivers and Opportunities
4.2.1.1. Aging Population and Rising Healthcare Needs
4.2.1.2. Government Support for MedTech Innovation
4.2.2. Restraints and Challenges
4.2.2.1. High reliance on imported raw materials increases vulnerability to supply chain disruptions and price volatility
4.3. Porter’s Five Forces Analysis
4.3.1. Bargaining Power of Suppliers (Moderate)
4.3.2. Threats of New Entrants: (Low)
4.3.3. Bargaining Power of Buyers (Moderate)
4.3.4. Threat of Substitute (Moderate)
4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. South Korea Medical Plastics Market Trends
4.6. Value Chain Analysis
5. South Korea Medical Plastics Market, by Polymer Type
5.1. Key Findings
5.2. Introduction
5.2.1. South Korea Medical Plastics Market, by Polymer Type, 2020-2034 (USD Million)
5.3. Thermoplastics
5.3.1. South Korea Medical Plastics Market, by Thermoplastics, 2020-2034 (USD Million)
5.3.2. Polypropylene (PP)
5.3.2.1. South Korea Medical Plastics Market, by Polypropylene (PP), 2020-2034 (USD Million)
5.3.3. Polyvinyl Chloride (PVC)
5.3.3.1. South Korea Medical Plastics Market, by Polyvinyl Chloride (PVC), 2020-2034 (USD Million)
5.3.4. Polyethylene (PE)
5.3.4.1. South Korea Medical Plastics Market, by Polyethylene (PE), 2020-2034 (USD Million)
5.3.5. Polycarbonate (PC)
5.3.5.1. South Korea Medical Plastics Market, by Polycarbonate (PC), 2020-2034 (USD Million)
5.3.6. Polyurethane
5.3.6.1. South Korea Medical Plastics Market, by Polyurethane, 2020-2034 (USD Million)
5.3.7. Acrylonitrile Butadiene Styrene (ABS)
5.3.7.1. South Korea Medical Plastics Market, by Acrylonitrile Butadiene Styrene (ABS), 2020-2034 (USD Million)
5.3.8. Others
5.3.8.1. South Korea Medical Plastics Market, by Others, 2020-2034 (USD Million)
5.4. Elastomers
5.4.1. South Korea Medical Plastics Market, by Elastomers, 2020-2034 (USD Million)
5.5. Biodegradable Polymers
5.5.1. South Korea Medical Plastics Market, by Biodegradable Polymers, 2020-2034 (USD Million)
5.6. Others
5.6.1. South Korea Medical Plastics Market, by Others, 2020-2034 (USD Million)
6. South Korea Medical Plastics Market, by Application
6.1. Key Findings
6.2. Introduction
6.2.1. South Korea Medical Plastics Market, by Application, 2020-2034 (USD Million)
6.3. Medical Instruments & Devices
6.3.1. South Korea Medical Plastics Market, by Medical Instruments & Devices, 2020-2034 (USD Million)
6.4. Medical Disposables
6.4.1. South Korea Medical Plastics Market, by Medical Disposables, 2020-2034 (USD Million)
6.5. Diagnostic Instruments & Tools
6.5.1. South Korea Medical Plastics Market, by Diagnostic Instruments & Tools, 2020-2034 (USD Million)
6.6. Others
6.6.1. South Korea Medical Plastics Market, by Others, 2020-2034 (USD Million)
7. South Korea Medical Plastics Market, by Manufacturing
7.1. Key Findings
7.2. Introduction
7.2.1. South Korea Medical Plastics Market, by Manufacturing, 2020-2034 (USD Million)
7.3. Extrusion Tubing
7.3.1. South Korea Medical Plastics Market, by Extrusion Tubing, 2020-2034 (USD Million)
7.4. Injection Molding
7.4.1. South Korea Medical Plastics Market, by Injection Molding, 2020-2034 (USD Million)
7.5. Compression Molding
7.5.1. South Korea Medical Plastics Market, by Compression Molding, 2020-2034 (USD Million)
7.6. Others
7.6.1. South Korea Medical Plastics Market, by Others, 2020-2034 (USD Million)
8. Competitive Landscape
8.1. Expansion and Acquisition Analysis
8.1.1. Expansion
8.1.2. Acquisitions
8.2. Partnerships/Collaborations/Agreements/Exhibitions
9. Company Profiles
9.1. Arkema
9.1.1. Company Overview
9.1.2. Financial Performance
9.1.3. Product Benchmarking
9.1.4. Recent Development
9.2. BASF
9.2.1. Company Overview
9.2.2. Financial Performance
9.2.3. Product Benchmarking
9.2.4. Recent Development
9.3. Celanese Corporation
9.3.1. Company Overview
9.3.2. Financial Performance
9.3.3. Product Benchmarking
9.3.4. Recent Development
9.4. Covestro
9.4.1. Company Overview
9.4.2. Financial Performance
9.4.3. Product Benchmarking
9.4.4. Recent Development
9.5. Dow
9.5.1. Company Overview
9.5.2. Financial Performance
9.5.3. Product Benchmarking
9.5.4. Recent Development
9.6. Eastman Chemical Company
9.6.1. Company Overview
9.6.2. Financial Performance
9.6.3. Product Benchmarking
9.6.4. Recent Development
9.7. Evonik Industries AG
9.7.1. Company Overview
9.7.2. Financial Performance
9.7.3. Product Benchmarking
9.7.4. Recent Development
9.8. INEOS
9.8.1. Company Overview
9.8.2. Financial Performance
9.8.3. Product Benchmarking
9.8.4. Recent Development
9.9. Kraton Corporation
9.9.1. Company Overview
9.9.2. Financial Performance
9.9.3. Product Benchmarking
9.9.4. Recent Development
9.10. LG Chem
9.10.1. Company Overview
9.10.2. Financial Performance
9.10.3. Product Benchmarking
9.10.4. Recent Development
9.11. SABIC
9.11.1. Company Overview
9.11.2. Financial Performance
9.11.3. Product Benchmarking
9.11.4. Recent Development
9.12. Solvay
9.12.1. Company Overview
9.12.2. Financial Performance
9.12.3. Product Benchmarking
9.12.4. Recent Development
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.